Evidence Hub

Metformin Toxicity in Chronic Kidney Disease: A Case Report of Severe Lactic Acidosis

Aalia P. S., Farisa T. A., L. R., Binu Upendran, P. Thomas

International Journal of Medical and Pharmaceutical Case Reports, 2025

Abstract

Metformin is one of the most commonly prescribed oral antihyperglycemic medicine worldwide. Professional diabetes organizations recommend it as the first-line treatment for newly diagnosed type 2 diabetes. Metformin is widely regarded as safe. The most common side effects include nausea, vomiting and diarrhea. Metformin-associated lactic acidosis (MALA) is a rare but serious adverse effect of metformin. Here, we are reporting a case of an elderly patient hospitalized with severe lactic acidosis presented with complaints of hypotension, decreased food intake, multiple episodes vomiting, dyspnoea, related to the treatment of type 2 diabetes with metformin. The patient was treated with emergency dialysis, vasopressor therapy and Inj Sodium bicarbonate.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free